New Horizon Health Ltd. has filed an application for the appointment of joint provisional liquidators (JPLs) with the Grand Court, scheduled for a hearing on August 6, 2025. This step aims to transfer the company's business and affairs to independent professional court officers to safeguard shareholder interests. The JPLs, if appointed, will investigate issues highlighted in previous announcements and explore potential restructuring options. Trading of the company's shares remains suspended since March 28, 2024, pending further updates. Shareholders and investors are advised to exercise caution when dealing with the company's securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.